ArticleEnvironmental science & technology2025
Acrolein-Induced Alterations in Morphology and Stress Resilience in hiPSC-Derived Cortical Neurons.
Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reactive carbonyl species in health and chronic disease: from methylglyoxal to an integrative network of metabolic regulation.Cardiovascular diabetology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Acrolein, an α,β-unsaturated aldehyde and reactive oxygen species (ROS), originates from both endogenous mechanisms, such as lipid peroxidation, and exogenous sources, including the decomposition of organic matter. Elevated levels of acrolein are detected in the brains of individuals with Alzheimer's and Parkinson's diseases, as well as those with traumatic brain or spinal cord injuries. Environmental exposure, including smoking and industrial emissions, further contribute to acrolein accumulation. Despite their recognized immediate neurotoxic effects, the chronic implications on neurodegeneration remain elusive. To elucidate these effects, human induced pluripotent stem cell (hiPSC)-derived human cortical neurons (∼Day 60 postdifferentiation) were subjected to 0, 1, and 10 μM concentrations of acrolein for 2 days following a nonexposure relaxation period (7 days) to assess the persistence of the resulting phenotypes. Immunofluorescence and calcium imaging demonstrated sustained alterations in the synaptic density and neuronal activity in acrolein-exposed differentiated neurons. Moreover, a persistent and dose-dependent neuronal hyperactivity was identified through microelectrode array analysis. Acrolein exposure also precipitated sustained elevations in Alzheimer's Disease-related phosphorylated Tau (p-tau) pathology and mitochondrial stress, along with diminished cellular resilience to subsequent stressors. Collectively, these findings support a persistent neurotoxic effect of acrolein, highlighting its potential implications for neurodegenerative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.